← Eichor
Study identifier: NCT06439563 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers

Condition: Peptic Ulcer  ·  Sponsor: Onconic Therapeutics Inc.

PhasePhase 3
Planned participants364
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersNo

About this study

The sutdy aims to to demonstrate the non-inferiority of JP-1366 10 mg compared to Lanston Capsule 15 mg in preventing NSAIDs-induced peptic ulcers and to compare/evaluate the efficacy and safety of JP-1366 10 mg.

This description comes directly from the study's public registry record.

Talk to the study team

John KIM  ·  0234540780  ·  onconictherapeutics@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Konkuk University Medical CenterSeoul, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06439563